Your browser doesn't support javascript.
loading
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity.
Brockow, Knut; Ardern-Jones, Michael R; Mockenhaupt, Maja; Aberer, Werner; Barbaud, Annick; Caubet, Jean-Christoph; Spiewak, Radoslaw; Torres, María José; Mortz, Charlotte G.
Affiliation
  • Brockow K; Department of Dermatology und Allergology Biederstein, Technical University of Munich, Munich, Germany.
  • Ardern-Jones MR; Department of Dermatology, Southampton General Hospital, University Hospitals Southampton NHS Foundation Trust, Southampton, UK.
  • Mockenhaupt M; Department of Dermatoimmunology, Sir Henry Wellcome Laboratories, Clinical, Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Aberer W; "Dokumentationszentrum schwerer Hautreaktionen" (dZh), Department of Dermatology, Medical Center and Medical Faculty, University of Freiburg, Freiburg, Germany.
  • Barbaud A; Department of Dermatology, Medical University of Graz, Graz, Austria.
  • Caubet JC; Department of Dermatology and Allergology, Tenon Hospital (AP-HP), Sorbonne Universities, Pierre et Marie Curie University, Paris 6, France.
  • Spiewak R; Pediatric Allergology Unit, Geneva University Hospitals, Geneva, Switzerland.
  • Torres MJ; Department of Experimental Dermatology and Cosmetology, Jagiellonian University Medical College, Krakow, Poland.
  • Mortz CG; Allergy Unit, IBIMA- Regional University Hospital of Malaga-UMA, Aradyal, Malaga, Spain.
Allergy ; 74(1): 14-27, 2019 01.
Article in En | MEDLINE | ID: mdl-30028512

Full text: 1 Database: MEDLINE Main subject: Skin / Drug Hypersensitivity Type of study: Guideline Limits: Humans Language: En Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Skin / Drug Hypersensitivity Type of study: Guideline Limits: Humans Language: En Year: 2019 Type: Article